Pliant Therapeutics, Inc. financial data

Symbol
PLRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
260 Littlefield Avenue, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.81 K % +18%
Debt-to-equity 10.4 % -6.07%
Return On Equity -35.1 % +10.2%
Return On Assets -31.8 % +9.61%
Operating Margin -78.4 K % -5328%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.3 M shares +2.35%
Common Stock, Shares, Outstanding 60.3 M shares +2.27%
Entity Public Float 1.01 B USD +258%
Common Stock, Value, Issued 6 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 60.2 M shares +7.36%
Weighted Average Number of Shares Outstanding, Diluted 60.2 M shares +7.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 248 K USD -97.5%
Research and Development Expense 136 M USD +28.8%
General and Administrative Expense 59 M USD +29.6%
Operating Income (Loss) -194 M USD -37.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -171 M USD -28.6%
Earnings Per Share, Basic -2.86 USD/shares -1.06%
Earnings Per Share, Diluted -2.86 USD/shares -1.06%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 114 M USD +11.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 490 M USD -16.7%
Property, Plant and Equipment, Net 5.61 M USD +33.5%
Operating Lease, Right-of-Use Asset 24.2 M USD +403%
Other Assets, Noncurrent 392 K USD -39.1%
Assets 522 M USD -12.8%
Accounts Payable, Current 7.33 M USD +416%
Employee-related Liabilities, Current 4.54 M USD +31.7%
Accrued Liabilities, Current 5.87 M USD
Liabilities, Current 30.4 M USD +31.3%
Operating Lease, Liability, Noncurrent 23.9 M USD +738%
Liabilities 84.3 M USD +134%
Accumulated Other Comprehensive Income (Loss), Net of Tax -489 K USD +63.3%
Retained Earnings (Accumulated Deficit) -547 M USD -45.4%
Stockholders' Equity Attributable to Parent 437 M USD -22.2%
Liabilities and Equity 522 M USD -12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.3 M USD +0.02%
Net Cash Provided by (Used in) Financing Activities 21.8 M USD -92%
Net Cash Provided by (Used in) Investing Activities 59.5 M USD
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 60.3 M shares +2.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 51.1 M USD -25.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 116 M USD +12.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 501 K USD +77.7%
Deferred Tax Assets, Valuation Allowance 154 M USD +45.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 155 M USD +43.4%
Operating Lease, Liability 6.45 M USD
Depreciation 1.9 M USD +4.51%
Payments to Acquire Property, Plant, and Equipment 1.49 M USD +815%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -170 M USD -27.6%
Lessee, Operating Lease, Liability, to be Paid 35.9 M USD +531%
Property, Plant and Equipment, Gross 14.8 M USD +28.8%
Operating Lease, Liability, Current 773 K USD -67.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.54 M USD +194%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.85 M USD +17.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.2 M USD +2350%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.74 M USD
Deferred Tax Assets, Operating Loss Carryforwards 78.5 M USD +19.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 7.97 M USD +53.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6 M USD
Operating Lease, Payments 3.85 M USD +44.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 42.2 M USD +36.3%
Interest Expense 1.4 M USD +27.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares